128 related articles for article (PubMed ID: 7783128)
1. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
Atwal KS; Grover GJ; Ferrara FN; Ahmed SZ; Sleph PG; Dzwonczyk S; Normandin DE
J Med Chem; 1995 May; 38(11):1966-73. PubMed ID: 7783128
[TBL] [Abstract][Full Text] [Related]
2. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
Atwal KS; Ferrara FN; Ding CZ; Grover GJ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
J Med Chem; 1996 Jan; 39(1):304-13. PubMed ID: 8568821
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
4. Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
Ding CZ; Rovnyak GC; Misra RN; Grover GJ; Miller AV; Ahmed SZ; Kelly Y; Normandin DE; Sleph PG; Atwal KS
J Med Chem; 1999 Sep; 42(18):3711-7. PubMed ID: 10479302
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Atwal KS
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075.
Sargent CA; Sleph PG; Dzwonczyk S; Normandin D; Antonaccio MJ; Grover GJ
J Cardiovasc Pharmacol; 1993 Oct; 22(4):564-70. PubMed ID: 7505358
[TBL] [Abstract][Full Text] [Related]
7. Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
Atwal KS; Grover GJ; Ahmed SZ; Ferrara FN; Harper TW; Kim KS; Sleph PG; Dzwonczyk S; Russell AD; Moreland S
J Med Chem; 1993 Nov; 36(24):3971-4. PubMed ID: 8254626
[No Abstract] [Full Text] [Related]
8. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
[TBL] [Abstract][Full Text] [Related]
9. Cardioselective antiischemic ATP-sensitive potassium channel (KATP) openers. 5. Identification of 4-(N-aryl)-substituted benzopyran derivatives with high selectivity.
Rovnyak GC; Ahmed SZ; Ding CZ; Dzwonczyk S; Ferrara FN; Humphreys WG; Grover GJ; Santafianos D; Atwal KS; Baird AJ; McLaughlin LG; Normandin DE; Sleph PG; Traeger SC
J Med Chem; 1997 Jan; 40(1):24-34. PubMed ID: 9016325
[TBL] [Abstract][Full Text] [Related]
10. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. 3. Structure-activity studies on benzopyranyl cyanoguanidines: modification of the cyanoguanidine portion.
Atwal KS; Grover GJ; Ahmed SZ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
J Med Chem; 1995 Aug; 38(17):3236-45. PubMed ID: 7650676
[TBL] [Abstract][Full Text] [Related]
11. A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog.
D'Alonzo AJ; Darbenzio RB; Sewter JC; Hess TA; Grover GJ; Sleph PG; Normandin DE; Lodge NJ
Eur J Pharmacol; 1995 Dec; 294(1):271-80. PubMed ID: 8788441
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Grover GJ
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
[TBL] [Abstract][Full Text] [Related]
14. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
[TBL] [Abstract][Full Text] [Related]
15. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of vasorelaxant effects of BMS-180448, a novel cardioselective ATP-sensitive potassium channel opener, in rat aorta.
Park YS; Yoo SE; Shin HS; Jin YR; Yun YP
J Pharmacol Sci; 2003 Jul; 92(3):218-27. PubMed ID: 12890887
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
19. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Kwan YW; To KW; Lau WM; Tsang SH
Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
